Gamgee is an Australian biotechnology startup developing AI-powered personalized mRNA cancer vaccines for dogs. The company uses a data-driven platform that integrates tumor sequencing, AI protein modeling, and automated vaccine design to deliver rapid, targeted immunotherapies and aims to industrialize production through a SaaS-based production line.